These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6895273)

  • 41. [Acid anti-secretion therapy in gastric and duodenal ulcer].
    Lattanzi A
    Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effectiveness of cimetidine, pirenzepine and synthetic secretin on stimulated gastric acid secretion].
    Londong W; Londong V; Prechtl R; Schwanner A
    Z Gastroenterol; 1980 Jun; 18(6):306-13. PubMed ID: 6893378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled double-blind study of the therapeutic effect of pirenzepine dihydrochloride in duodenal ulcer. Phase III study.
    Ishimori A; Yamagata S
    Arzneimittelforschung; 1986 Jun; 36(6):980-3. PubMed ID: 3527182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pirenzepin].
    Brunner H
    Wien Med Wochenschr; 1983; 133(4-5):108-11. PubMed ID: 6344444
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of pirenzepine on meal-stimulated acid secretion and gastrin release in normal man.
    Mignon M; Vatier J; Bauer P; Bonfils S
    Scand J Gastroenterol Suppl; 1982; 72():145-51. PubMed ID: 6753112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of gastric acid secretion by gastrin in duodenal ulcer patients and healthy subjects.
    Eysselein VE; Kovacs TO; Kleibeuker JH; Maxwell V; Reedy T; Walsh JH
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1142-8. PubMed ID: 1551523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Inhibition of nocturnal acid secretion by pirenzepine (author's transl)].
    Dammann HG; Simon B; Müller P; Krüger HJ
    Arzneimittelforschung; 1982; 32(3):309-10. PubMed ID: 7044387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Bianchi Porro G
    Hepatogastroenterology; 1992 Aug; 39(4):366-70. PubMed ID: 1427586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pirenzepine, cimetidine and placebo in the long-term treatment of duodenal ulceration. A comparative study.
    Moshal MG; Spitaels JM; Khan F; Manion GL
    S Afr Med J; 1982 Jul; 62(1):12-4. PubMed ID: 7046098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pirenzepin in gastric and duodenal ulcer: a double-blind trial.
    Cerlek S; Papa B; Katicić M; Colić-Cvrlje V; Mielenz H
    J Int Med Res; 1981; 9(2):148-51. PubMed ID: 7014285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of inhibitors of acid secretion in patients with duodenal ulcer. Comparative study of cimetidine, ranitidine and pirenzepine].
    Espinoza M; Csendes A; Medina LA; Fuster F; Braghetto I; Encina J
    Rev Med Chil; 1984 Nov; 112(11):1085-9. PubMed ID: 6152639
    [No Abstract]   [Full Text] [Related]  

  • 52. A double-blind, short-term clinical trial of pirenzepine in duodenal ulcer.
    Morelli A; Narducci F; Pelli MA; Spadacini A
    Scand J Gastroenterol Suppl; 1979; 57():45-9. PubMed ID: 396657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.
    Londong W; Londong V; Ruthe C; Weizert P
    Gut; 1981 Jul; 22(7):542-8. PubMed ID: 6114900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of pirenzepine on basal, pentagastrin- and insulin-stimulated gastric acid secretion in patients with peptic ulcer disease.
    Jaup BH; Stockbrügger R; Dotevall G
    Scand J Gastroenterol; 1979; 14(5):621-4. PubMed ID: 493866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Acid secretion and gastrin release following stimulation with intragastric instillation of a peptone solution in healthy probands and patients with duodenal ulcer].
    Gersmann A; Fritsch WP; Hausamen TU
    Z Gastroenterol; 1982 Oct; 20(10):604-12. PubMed ID: 7157903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Basal and postprandial blood gastrin in peptic ulcer. The physiopathological considerations in relation to different locations of the lesion].
    Gottardello L; Di Mario F; Pagano R; Cannizzaro R; Pasqualetti P; Farinati F; Faggian D; Plebani M; Naccarato R
    Minerva Med; 1989 Dec; 80(12):1293-9. PubMed ID: 2622571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Inhibition of carbonic anhydrase by pirenzepin].
    Puşcaş I; Búzás G; Surányi P; Domuţa M; Simonca M; Arcălean O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(1):65-8. PubMed ID: 6114536
    [No Abstract]   [Full Text] [Related]  

  • 58. [A global study of gastric secretion in duodenal ulcers: gastrin, pepsinogen and acid secretion].
    Gisbert JP; Boixeda D; Vila T; Martín de Argila C; Bermejo F; al-Mostafa A; de la Serna C
    Rev Esp Enferm Dig; 1995 Jul; 87(7):491-7. PubMed ID: 7662416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pirenzepine in the treatment of duodenal ulcer.
    D'Imperio N; Giuliani Piccari G; Lepore AM; Sarti F; Dal Monte PR
    Scand J Gastroenterol Suppl; 1979; 57():41-4. PubMed ID: 396656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastric acid secretion and the changes of blood gastrin, glucose and insulin levels following 2-deoxy-D-glucose administration in hypersecretory and normosecretory duodenal ulcer patients.
    Popiela T; Szafran H; Szafran Z; Sztefko K; Opławski B
    Acta Physiol Pol; 1982; 33(5-6):587-95. PubMed ID: 6764708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.